Norwegian study has found cognitive behavioral therapy (CBT) better at treating long-term insomnia than the sleep medication zopiclone, which is very similar to the widely advertised drug Lunesta.
The findings showed that CBT was superior to sleep medications for older individuals suffering from chronic insomnia. In fact, zopiclone did not perform better than placebo pills," said the study's lead author, Dr. Borge Sivertsen, an associate researcher at the Norwegian Competence Center for Sleep Disorders.
Additionally, "CBT increased the patients' slow-wave sleep (deep sleep) compared to a significant decrease caused by zopiclone. This finding is especially important, as a lack of slow wave sleep may be responsible for impaired daytime functioning and next-day sleepiness," he said.
Results of the study appear in the June 28 issue of the Journal of the American Medical Association.
According to the National Sleep Foundation (NSF), almost six of 10 Americans report having insomnia at least a few nights weekly. As many as 25 percent of people in the United States use medications to help them sleep at least once every year, according to the NSF. The use of prescription sleep medications, such as Ambien, Lunesta and Sonata, has been increasing, and while these drugs are effective for short-term sleeping problems, users can build up a tolerance to them and they lose their effectiveness, according to Susan Zafarlotfi, clinical director for the Institute for Sleep-Wake Disorders at Hackensack University Medical Center in New Jersey.
In the study, eighteen participants received cognitive behavioral therapy, which included six weekly individual treatment sessions in which they were given information on relaxation techniques, how to control their sleeping environment to reduce stimuli, and how to restrict sleeping hours so it's easier to fall asleep at bedtime. Sixteen people were given 7.5 milligrams of zopiclone nightly for six weeks. The remaining 12 volunteers received a placebo.
Study results were measured at six weeks and then again at six months for the medication and cognitive behavioral therapy group.
Those receiving CBT improved their "sleep efficiency" from 81.4 percent to 90.1 percent by the end of the 6-month study, while the zopiclone group decreased from 82.3 percent to 81.9 percent. While total sleep time was similar for all three groups at six months, people who received CBT spent more time in slow-wave sleep and woke up less during the night than people in the other two groups, according to the study.
Sivertsen said if you're having trouble sleeping, don't stay in bed. He said this can inhibit your body's sleep drive. Get up and do something non-stimulating until you feel as if you can sleep. He said it's very important to get up at the same time everyday, including on the weekends and to avoid taking daytime naps.
Other things that can help you sleep are avoiding alcohol, caffeine and nicotine in the hours before bedtime.
Read